Results for tag: "Pancreatic Adenocarcinoma Drug"

Pancreatic Adenocarcinoma is a type of cancer that affects the pancreas, a vital organ in the digestive system. Pancreatic Cancer Drugs are used to treat this type of cancer. These drugs are designed to target the cancer cells and stop them from growing and spreading. They can also be used to reduce the side effects of chemotherapy and radiation therapy. Commonly used drugs include gemcitabine, capecitabine, and erlotinib. The Pancreatic Adenocarcinoma Drug market is highly competitive, with many companies offering different treatments. Companies such as Merck, Bristol-Myers Squibb, and Roche are some of the major players in the market. Other companies include Celgene, AstraZeneca, and Novartis. These companies are constantly researching and developing new treatments to improve the quality of life for those affected by pancreatic cancer. Show Less Read more